As more and more patients begin using social media as an information source and a support network, it's inevitable that they'll begin to interact with representatives of pharmaceutical companies looking to use new technologies to inform and educate. While consumer-industry interactions are not new -- Comcast crawls Twitter for those in need of tech support, and Gatorade sends electronic high-fives to high school athletes -- links between drug companies and those they serve are more fraught, with some patients celebrating dialogue and others warning that such relationships are intrinsically inappropriate. This panel -- including patients, advocates and industry -- will explore the ground rules of "friending" big pharma and the ground rules that biopharma firms must play by to ensure patients aren't taken advantage of.
Speakers

CEO | The Staley Foundation | Alicia is a three-time cancer survivor...

Asst Editor | Diabetes Mine/Alliance Health | Allison Blass is...

Dir | WCG | Public relations is entering its most exciting phase...

Writer/Editor | Six Until Me | Kerri Sparling has been living...

AVP of Patient Insights & Analytics | US Sanofi Diabetes | As...

Vice President | Pfizer Inc
Type Interactive,
Panel
Hashtag #sxsw #FrndPhrm
Theme Health and Education
Level Intermediate
Website http://schedule.sxsw.com/2012/events/event_IAP11621
Sign up or log in to save this event to your list and see who's attending!